Medical News

RSS

Aptuit to acquire GSK's research business in Verona

GlaxoSmithKline (GSK) and Aptuit, Inc. announced today that they have finalized an agreement for Aptuit to acquire operations at GSK's Medicines Research Centre in Verona, Italy. The arrangement, which is effective as of July 1, 2010, provides for ongoing employment of the staff at the centre and for Aptuit to supply GSK with R&D services from the facilities. Financial terms have not been disclosed.

1 Jul 2010

IPC The Hospitalist Company acquires Austin Hospital Physicians

IPC The Hospitalist Company, Inc., a leading national hospitalist physician group practice company, announced today that it has acquired Austin Hospital Physicians, PA, (AHP) based in Austin, Texas. The acquisition represents a new market for IPC in Texas, adding to its well-established presence in the state. AHP has an annualized volume of approximately 9,000 patient encounters.

1 Jul 2010

IRIS submits 510(k) application for clearance of iChemVELOCITY and iRICELL Urinalysis Workstation

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that its IRIS Diagnostics Division submitted on June 30, 2010, a 510(k) pre-market notification application to the U.S. Food and Drug Administration (FDA) requesting regulatory clearance for its iChem®Velocity™ Automated Urine Chemistry Analyzer and iRICELL® Urinalysis Workstation.

1 Jul 2010

Euthymics and DOV sign merger agreement

Euthymics Bioscience, Inc., a privately held Delaware corporation, and DOV Pharmaceutical, Inc., a Delaware corporation currently traded on the Pink Sheets, today jointly announced that they have signed a merger agreement in connection with the pending merger and acquisition of DOV by Euthymics.

1 Jul 2010

FDA grants Cyclacel's sapacitabine orphan drug designation for AML and MDS

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's sapacitabine (CYC682) product candidate for the treatment of both acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).

1 Jul 2010

Prasco to sell and distribute authorized generic version of ZEGERID capsules

Prasco Laboratories announced today that it is now shipping the authorized generic version of ZEGERID® (omeprazole/sodium bicarbonate) capsules. Authorized generics are generic pharmaceuticals manufactured identically to the brand product and sold under a private label. Under the terms of a distribution and supply agreement with Santarus, Prasco will sell and distribute the capsule form of Omeprazole/Sodium Bicarbonate in 20 mg and 40 mg strengths in the U.S. under the Prasco label.

1 Jul 2010

Bacterin International completes reverse merger transaction

Bacterin International, Inc., a Nevada company, today announced that it has completed a reverse merger transaction with Bacterin International Holdings, Inc. f/k/a K-Kitz, in which the Company caused its wholly-owned subsidiary to be merged with and into Bacterin, with Bacterin as the surviving company.

1 Jul 2010

First Edition: July 1, 2010

Today's health policy headlines highlight news about the launch of a government health insurance web site and the start of the high-risk health insurance pools mandated in the health reform law.

1 Jul 2010

Survey: 66% of patients with metastatic colorectal cancer are now tested for KRAS

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, has revealed new results from a global survey demonstrating that 66% of patients with metastatic colorectal cancer (mCRC) are now tested for KRAS to determine if they could benefit from a personalized therapy, such as Erbitux® (cetuximab). This represents a 50% increase in levels of KRAS testing in just one year.

1 Jul 2010

Kilimani Sesame benefits Tanzanian children

There are 8.3 million children who are 5 years and younger living in Tanzania. With limited access to formal education, can media intervention make a positive and significant impact on what these children learn? Sesame Workshop, which produces Kilimani Sesame, the Tanzanian version of Sesame Street, recently commissioned researchers from the Johns Hopkins Bloomberg School of Public Health in full collaboration with a Dar es Salaam-based research team, to examine the effects of a six-week intervention delivering Kilimani Sesame content to 223 children.

1 Jul 2010

Study finds increased neonatal mortality among planned home births

About 1 in 200 women in the US delivers her baby at home, with approximately 75% of these low-risk, single-baby births planned in advance as home deliveries. In a study published online today by the American Journal of Obstetrics & Gynecology (AJOG), researchers from Maine Medical Center, Portland, Maine, analyzed the results of multiple studies from around the world.

1 Jul 2010

Uroplasty broadens neuromodulation patent portfolio

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today the issuance of United States Patent No. 7,729,772 which covers a method for using an implantable neuromodulation system in the treatment of urinary incontinence by neuromodulation or stimulation of the tibial nerve. The neuromodulation system includes a portable, external transmitter and a receiver implanted subcutaneously in the leg or ankle near the tibial nerve.

1 Jul 2010

University College London neurology professor becomes first recipient of Lord Brain Memorial Medal

Andrew Lees, Professor of Neurology at University College London, is to be the first ever recipient of the Lord Brain Memorial Medal - awarded for the scientific contributions he has made to the field of movement disorders within the UK. He will receive the medal following his delivery of the inaugural Lord Brain Memorial Lecture; "Brainwashed by the Black Stuff," at Barts and The London Medical School on June 24, 2010.

1 Jul 2010

Studies on VIAject and Vialog presented at 70th American Diabetes Association sessions

Studies of a more-rapid-acting injectable human insulin formulation (VIAject®) in the treatment of type 1 and type 2 diabetes and of a novel insulin analog formulation (Vialog™) in an animal model of diabetes were reported this week in three poster presentations at the 70th Scientific Sessions of the American Diabetes Association in Orlando, Florida. The findings are based upon results from recent clinical and preclinical studies sponsored by Biodel Inc..

1 Jul 2010

Investment report on BioElectronics

MicroStockProfit.com announces an investment report featuring BioElectronics Corp. The report includes financial, comparative and investment analyses, and recent company news that you need to know to make an educated investment decision.

1 Jul 2010

First analyses on impact of Medicare Part D presented at UMB's 2010 Academy/Health Annual Meeting

Some of the first analyses on the impact of Medicare Part D, as well as new insights on drug adherence patterns by chronic disease patients, will be presented today and tomorrow at the 2010 Academy/Health Annual Meeting by several University of Maryland, Baltimore teams of pharmaceutical health services researchers.

1 Jul 2010

Babies born after IVM fertility treatment more likely to be born larger than normal

A review of studies of babies born after in vitro maturation (IVM) fertility treatment has suggested that they are more likely to be born larger than normal and to have more difficult births requiring more obstetric interventions such as caesareans.

1 Jul 2010

AMP comments on array-based cytogenetic tests at FDA's public meeting

Today, the Association for Molecular Pathology presented comments at the US Food & Drug Administration's public meeting on array-based cytogenetic tests. The FDA convened the meeting to seek answers to more than a dozen questions they had on how to evaluate the performance, interpret results and report findings of array-based cytogenetic tests for copy number variation.

1 Jul 2010

New and expectant moms do not discuss preterm birth with healthcare providers, shows survey

A new survey shows a majority of new and expectant moms have not discussed preterm birth with their healthcare providers, despite the fact that early prenatal care, including discussion about lifestyle habits and medical history, may give babies a better chance of a healthy, full-term birth. This new survey, titled SPEAKing About Preterm Birth, was conducted among moms and healthcare providers including obstetricians/gynecologists and maternal fetal medicine specialists, by the March of Dimes and BabyCenter, and sponsored by Ther-Rx Corporation.

1 Jul 2010

AAO-HNS releases CCS to address ambiguities, disparities in diagnosis and management of nasal valve compromise

Today, the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) announced the release of a consensus statement to address ambiguities and disparities in the diagnosis and management of nasal valve compromise (NVC).

1 Jul 2010

Medical News

Aptuit to acquire GSK's research business in Verona

IPC The Hospitalist Company acquires Austin Hospital Physicians

IRIS submits 510(k) application for clearance of iChemVELOCITY and iRICELL Urinalysis Workstation

Euthymics and DOV sign merger agreement

FDA grants Cyclacel's sapacitabine orphan drug designation for AML and MDS

Prasco to sell and distribute authorized generic version of ZEGERID capsules

Bacterin International completes reverse merger transaction

First Edition: July 1, 2010

Survey: 66% of patients with metastatic colorectal cancer are now tested for KRAS

Kilimani Sesame benefits Tanzanian children

Study finds increased neonatal mortality among planned home births

Uroplasty broadens neuromodulation patent portfolio

University College London neurology professor becomes first recipient of Lord Brain Memorial Medal

Studies on VIAject and Vialog presented at 70th American Diabetes Association sessions

Investment report on BioElectronics

First analyses on impact of Medicare Part D presented at UMB's 2010 Academy/Health Annual Meeting

Babies born after IVM fertility treatment more likely to be born larger than normal

AMP comments on array-based cytogenetic tests at FDA's public meeting

New and expectant moms do not discuss preterm birth with healthcare providers, shows survey

AAO-HNS releases CCS to address ambiguities, disparities in diagnosis and management of nasal valve compromise

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News